SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-129461
Filing Date
2024-05-02
Accepted
2024-05-02 16:57:55
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFA14A d793569ddefa14a.htm DEFA14A 25710
2 GRAPHIC g793569g00a02.jpg GRAPHIC 62218
3 GRAPHIC g793569g00a06.jpg GRAPHIC 24290
4 GRAPHIC g793569g55m08.jpg GRAPHIC 4903
5 GRAPHIC g793569gra03b.jpg GRAPHIC 1687
6 GRAPHIC g793569gra03d.jpg GRAPHIC 1361
7 GRAPHIC g793569gra03e.jpg GRAPHIC 1244
8 GRAPHIC g793569gra03f.jpg GRAPHIC 1290
9 GRAPHIC g793569gra03g.jpg GRAPHIC 2721
  Complete submission text file 0001193125-24-129461.txt   165371
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 843562323 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39248 | Film No.: 24909429
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)